CLL Global Funded Research | Dr. Jennifer Woyach & Dr. Deepa Sampath
CLL researchers, Dr. Jennifer Woyach and Dr. Deep Sampath, discuss how they work together and their currently funded CLL Global Research Foundation project.
CLL Global Research Foundation President | Dr. William Wierda
William Wierda, President and CEO of the CLL Global Research Foundation discusses his hope for the future of the organization.
Advances in CLL Treatment and Research | The Impact of CLL Global Research Foundation
Dr. George Calin discusses his current research projects that are funded by the CLL Global Research Foundation and shares how the organization has impacted the field of CLL over the years.
What CLL Patients Should Know About RSV and COVID Vaccines
Experts respond to a viewer question about vaccinations for COVID and RSV as it relates to people with CLL.
Is CLL Now a Highly Treatable Condition?
Dr. William Wierda and Dr. Patrick Reville discussed the long-term treatment and management of CLL.
Understanding Data from the TRANSCEND Trial | CAR T-Cell Therapy for CLL
Experts responded to viewer questions about CAR T-cell therapy during the Feb 7, 2024 virtual town hall.
CLL Global Research Foundation | Research Updates
Dr. William Wierda discussed the latest research funded by the CLL Global Research Foundation during the Feb 7, 2024 virtual town hall.
How Do You Know When CLL Treatment Should Begin?
Experts responded to a viewer question about the CLL watch & wait period during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Understanding What the CLL 10-Year Progression-Free Survival of Ibrutinib Means
Experts explained the meaning of the CLL 10-year progression-free survival of Ibrutinib during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.
Are CLL Patients At-Risk for AML or CML?
Experts responded to a viewer question about the risk of AML and CML during the Feb 7, 2024 CLL Global Research Foundation virtual town hall.